Stepan Company Reports $18.5 Million Net Loss Amid Restructuring Efforts

Stepan Company reported a net loss of $18.5 million, or $0.81 per diluted share, for the six months ended June 30, 2026, a significant decline from the net income of $31.1 million, or $1.36 per diluted share, recorded in the same period of 2025. The loss was primarily attributed to $70.5 million in restructuring charges related to the company's Project Catalyst initiative, which aims to enhance operational efficiency. In contrast, adjusted net income for the first half of 2026 was $37.4 million, or $1.63 per diluted share, compared to $31.3 million, or $1.37 per diluted share, in the prior year.

Total consolidated net sales for the first half of 2026 increased by $100.7 million, or 8%, reaching $1.29 billion, driven by higher average selling prices that contributed $56.1 million to the increase. The company noted that foreign currency translation also positively impacted sales by $42.4 million due to a weaker U.S. dollar. Sales volume saw a modest increase of less than 1%, with organic sales volume rising by 3%. The Surfactants segment, which accounted for 73% of total sales, reported an 11% increase in net sales, while the Polymers segment remained relatively stable with a slight decline.

In terms of operational developments, Stepan Company is undergoing significant restructuring as part of its Project Catalyst initiative, which includes the shutdown of its Fieldsboro, New Jersey site and the decommissioning of select assets at its Elwood, Illinois and Stalybridge, U.K. facilities. The restructuring efforts are expected to yield long-term cost savings and improved asset utilization. The company anticipates total restructuring expenses for 2026 to be in the range of $75 million to $80 million.

The company’s cash flow from operating activities for the first half of 2026 was $25.3 million, an increase from $18.1 million in the same period of 2025. However, cash used in investing activities decreased to $46.3 million from $51.5 million year-over-year. As of June 30, 2026, Stepan Company had cash and cash equivalents totaling $113.7 million, reflecting a decrease of $19 million from the end of 2025. The company’s total debt increased to $647.4 million, primarily due to higher borrowings from its revolving credit facility.

Looking ahead, Stepan Company remains focused on executing its strategic initiatives, including Project Catalyst, to enhance operational efficiency and reduce costs. The company expects to continue navigating market challenges while leveraging its diverse product portfolio across its three segments: Surfactants, Polymers, and Specialty Products. The management believes that the company's liquidity is sufficient to meet its operational needs and planned capital expenditures in the near term.